Literature DB >> 19682571

Regulation of neuron mitochondrial biogenesis and relevance to brain health.

Isaac G Onyango1, Jianghua Lu, Mariana Rodova, E Lezi, Adam B Crafter, Russell H Swerdlow.   

Abstract

Mitochondrial dysfunction has severe cellular consequences, and is linked to aging and neurological disorders in humans. Impaired energy supply or Ca(2+) buffering, increased ROS production, or control of apoptosis by mitochondria may contribute to the progressive decline of long-lived postmitotic cells. Mitochondrial biogenesis refers to the process via which cells increase their individual mitochondrial mass. Mitochondrial biogenesis may represent an attempt by cells to increase their aerobic set point, or an attempt to maintain a pre-existing aerobic set point in the face of declining mitochondrial function. Neuronal mitochondrial biogenesis itself has been poorly studied, but investigations from other tissues and model systems suggest a series of transcription factors, transcription co-activators, and signal transduction proteins should function to regulate mitochondrial number and mass within neurons. We review data pertinent to the mitochondrial biogenesis field, and discuss implications for brain aging and neurodegenerative disease research efforts.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19682571     DOI: 10.1016/j.bbadis.2009.07.014

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  62 in total

1.  Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease.

Authors:  Baiyang Sheng; Xinglong Wang; Bo Su; Hyoung-gon Lee; Gemma Casadesus; George Perry; Xiongwei Zhu
Journal:  J Neurochem       Date:  2011-12-08       Impact factor: 5.372

Review 2.  Role of mitochondrial homeostasis and dynamics in Alzheimer's disease.

Authors:  J Eva Selfridge; Lezi E; Jianghua Lu; Russell H Swerdlow
Journal:  Neurobiol Dis       Date:  2012-01-10       Impact factor: 5.996

Review 3.  The Alzheimer's disease mitochondrial cascade hypothesis.

Authors:  Russell H Swerdlow; Jeffrey M Burns; Shaharyar M Khan
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 4.  Pathogenic implications of iron accumulation in multiple sclerosis.

Authors:  Rachel Williams; Cassandra L Buchheit; Nancy E J Berman; Steven M LeVine
Journal:  J Neurochem       Date:  2011-11-11       Impact factor: 5.372

Review 5.  Bioenergy sensing in the brain: the role of AMP-activated protein kinase in neuronal metabolism, development and neurological diseases.

Authors:  Stephen Amato; Heng-Ye Man
Journal:  Cell Cycle       Date:  2011-10-15       Impact factor: 4.534

6.  Voluntary exercise promotes beneficial anti-aging mechanisms in SAMP8 female brain.

Authors:  Sergi Bayod; Carolina Guzmán-Brambila; Sandra Sanchez-Roige; Jaume F Lalanza; Perla Kaliman; Daniel Ortuño-Sahagun; Rosa M Escorihuela; Mercè Pallàs
Journal:  J Mol Neurosci       Date:  2014-07-16       Impact factor: 3.444

7.  Sodium butyrate epigenetically modulates high-fat diet-induced skeletal muscle mitochondrial adaptation, obesity and insulin resistance through nucleosome positioning.

Authors:  Tara M Henagan; Barbara Stefanska; Zhide Fang; Alexandra M Navard; Jianping Ye; Natalie R Lenard; Prasad P Devarshi
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

8.  A Mitochondrial Biomarker-Based Study of S-Equol in Alzheimer's Disease Subjects: Results of a Single-Arm, Pilot Trial.

Authors:  Heather M Wilkins; Jonathan D Mahnken; Paul Welch; Rebecca Bothwell; Scott Koppel; Richard L Jackson; Jeffrey M Burns; Russell H Swerdlow
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

9.  ALS spinal neurons show varied and reduced mtDNA gene copy numbers and increased mtDNA gene deletions.

Authors:  Paula M Keeney; James P Bennett
Journal:  Mol Neurodegener       Date:  2010-05-26       Impact factor: 14.195

10.  Improved mitochondrial function in brain aging and Alzheimer disease - the new mechanism of action of the old metabolic enhancer piracetam.

Authors:  Kristina Leuner; Christopher Kurz; Giorgio Guidetti; Jean-Marc Orgogozo; Walter E Müller
Journal:  Front Neurosci       Date:  2010-09-07       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.